FOXM1 and small cell lung carcinoma: Subcutaneous xenograft and SCLC spontaneous (RPM: RBfl/fl;TP53fl/fl;LSL-MYCT58A) mouse models were used to evaluate the efficacy of FOXM1 inhibitors.